Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas

Neurosurgery

Volumn 62, Issue 1, 2008, Pages 61-69

  Ketter, Ralf ^a   Rahnenführer, Jörg ^b   Henn, Wolfram ^a   Kim, Yoo Jin ^a   Feiden, Wolfgang ^a   Steudel, Wolf Ingo ^a   Zang, Klaus D ^a   Urbschat, Steffi ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b TU DORTMUND UNIVERSITY   (Germany)

Author keywords

Chromosomes; Genetic progression score; Meningioma; Tumor localization

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; CHROMOSOME DELETION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MENINGIOMA; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; TUMOR CELL; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR RECURRENCE; AGED; CHROMOSOME ABERRATION; DISEASE COURSE; FOLLOW UP; GENETICS; KARYOTYPING; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; THEORETICAL MODEL;

ADULT; AGED; CHROMOSOME ABERRATIONS; CYTOGENETICS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KARYOTYPING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 41749086020     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000311062.72626.D6     Document Type: Article

References (50)

1. Adegbite AB, Khan MI, Paine KW, Tan LK: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51-56, 1983.
2. Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M: Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210-218, 2004.
3. Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M: Positron emission tomography in patients with glioma: A predictor of prognosis. Cancer 62:1074-1078, 1988.
4. Ayerbe J, Lobato RD, de la Cruz J, Alday R, Rivas JJ, Gómez PA, Cabrera A: Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir (Wein) 141:921-932, 1999.
5. Beerenwinkel N, Rahnenführer J, Däumer M, Hoffmann D, Kaiser R, Selbig J, Lengauer T: Learning multiple evolutionary pathways from cross-sectional data. J Comput Biol 12:584-598, 2005.
6. Beerenwinkel N, Rahnenführer J, Kaiser R, Hoffmann D, Selbig J, Lengauer T: Mtreemix: A software package for learning and using mixture models of mutagenetic trees. Bioinformatics 21:2106-2107, 2005.
7. Beks JW, de Windt HL: The recurrence of supratentorial meningiomas after surgery. Acta Neurochir (Wein) 95:3-5, 1988.
8. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestaña A, Rey JA: Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 9:296-298, 1994.
9. Cushing H: The cranial hyperostoses produced by meningeal endotheliomas. Arch Neurol Psychiatry 8:139-152, 1922.
10. Di Chiro G, Hatazawa J, Katz DA, Rizzoli HV, De Michele DJ: Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. Radiology 164:521-526, 1987.
11. DiMeco F, Li KW, Casali C, Ciceri E, Giombini S, Filippini G, Broggi G, Solero CL: Meningiomas invading the superior sagittal sinus: surgical experience in 108 cases. Neurosurgery 55:1263-1274, 2004.
12. Espinosa AB, Tabernero MD, Maíllo A, Sayagués JM, Ciudad J, Merino M, Alguero MC, Lubombo AM, Sousa P, Santos-Briz A, Orfao A: The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse. Clin Cancer Res 12:772-780, 2006.
13. Giombini S, Solero CL, Lasio G, Morello G: Immediate and late outcome of operations for Parasagittal and falx meningiomas. Report of 342 cases. Surg Neurol 21:427-435, 1984.
14. Giombini S, Solero CL, Morello G: Late outcome of operations for supratentorial convexity meningiomas. Report on 207 cases. Surg Neurol 22:588-594, 1984.
15. Goldsmith BJ, Wara WM, Wilson CB, Larson DA: Postoperative irradiation for subtotally resected meningiomas. At retrospective analysis of 140 patients treated from 1967-1990. J Neurosurg 80:195-201, 1994.
16. Henn W, Cremerius U, Heide G, Lippitz B, Schröder JM, Gilsbach JM, Büll U, Zang KD: Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas. Cancer Genet Cytogenet 79:144-148, 1995.
17. Ildan F, Tuna M, Göçer AP, Boyar B, Baǧdatoǧlu H, Sen O, Haciyakupoǧlu S, Burgut HR: Correlation of the relationships of brain-tumor interfaces, magnetic resonance imaging, and angiographic findings to predict cleavage of meningiomas. J Neurosurg 91:384-390, 1999.
18. Jellinger K: Histopathological features predicting recurrence of meningiomas after (sub)total resection. Clin Neuropathol 7:174, 1988.
19. Kepes JJ: Meningiomas, Biology, Pathology and Differential Diagnosis. New York, Masson Publishing, 1982.
20. Ketter R, Henn W, Niedermayer I, Steilen-Gimbel H, König J, Zang KD, Steudel WI: Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 95:601-607, 2001.
21. Ketter R, Kim YJ, Storck S, Rahnenführer J, Romeike BF, Steudel WI, Zang KD, Henn W: Hyperdiploidy defines a distinct cytogenetic entity of meningiomas. J Neurooncol 83:213-221, 2007.
22. Ketter R, Urbschat S, Henn W, Feiden W, Beerenwinkel N, Lengauer T, Steudel WI, Zang KD, Rahnenführer J: Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas. Int J Cancer 121:1473-1480, 2007.
23. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993.
24. Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, Zang KD, Feiden W: Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Wein) 137:174-181, 1995.
25. Limon J, Dal Cin P, Sandberg AA: Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 23:305-313, 1986.
26. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ: Meningiomas, in Kleihues P, Cavenee WK (eds): Pathology and Genetics. Tumors of the nervous system. Lyon, IARC Press, 2000.
27. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM: Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33:955-963, 1993.
28. Mahmood A, Qureshi NH, Malik GM: Intracranial menigiomas: analysis of recurrence after surgical treatment. Acta Neurochir (Wein) 126:53-58, 1994.
29. McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Meneck HR, Laws ER Jr: Factors associated with survival in patients with meningioma. J Neurosurg 88:831-839, 1998.
30. McLean CA, Jolley D, Cukier E, Giles G, Gonzales MF: Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology 23:349-353, 1993.
31. Menon AG, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF, Houseal TW: Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative 'tumor progression' locus. Oncogene 14:611-616, 1997.
32. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL: Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62:18-24, 1985.
33. Møller ML, Braendstrup O: No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry. J Neurooncol 34:241-246, 1997.
34. Müeller P, Henn W, Niedermayer I, Ketter R, Feiden W, Steudel WI, Zang KD, Steilen-Gimbel H: Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res 5:3569-3577, 1999.
35. Niedermayer I, Feiden W, Henn W, Steilen-Gimbel H, Steudel WI, Zang KD: Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 56:879-886, 1997.
36. Palma L, Celli P, Franco C, Cervoni L, Cantore G: Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. J Neurosurg 86:793-800, 1997.
37. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM: Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:1455-1465, 1997.
38. Philippon J, Bataini JP, Cornu PR, Grob R, Kujas M, Poisson M, Rivierez M: Recurrent meningioma [in French]. Neurochirurgie 32 [Suppl 1]:1-84, 1986.
39. Rahnenführer R, Beerenwinkel N, Schulz WA, Hartmann C, von Deimling A, Wullich B, Lengauer T: Estimating cancer survival and clinical outcome based on genetic tumor progession scores. Bioinformatics 21:2438-2446, 2005.
40. Sayagués JM, Tabernero MD, Maíllo A, Espinosa A, Rasillo A, Díaz P, Ciudad J, López A, Merino M, Gonçalves JM, Santos-Briz A, Morales F, Orfao A: Intratumoral patterns of clonal evolution in meningiomas as defined by Multicolor Interphase Fluorescence in Situ Hybridization (FISH): Is there a relationship between histopathologically benign and atypical/anaplastic lesions? J Mol Diagn 6:316-325, 2004.
41. Scheithauer BW: Tumors of the meninges: proposed modifications of the World Health Organization classification. Acta Neuropathol (Berl) 80:343-354, 1990.
42. Simon M, von Deimling A, Larson JJ, Wellenreuter R, Kaskel P, Waha A, Warnick RE, Tew JM Jr, Menon AG: Allelic losses on chromosomes 14, 10 and 1 in atypical and malignant meningiomas: A genetic model of meningioma progression. Cancer Res 55:4696-4701, 1995.
43. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39, 1957.
44. Solero CL, Fornari M, Giombini S, Lasio G, Oliveri G, Cimino C, Pluchino F: Spinal meningiomas: review of 174 operated cases. Neurosurgery 25: 153-160, 1989.
45. Takeuchi H, Kubota T, Kabuto M, Kitai R, Nozaki J, Yamashita J: Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study. Surg Neurol 48:501-506, 1997.
46. Weber RG, Boström J, Wolter M, Baudis M, Collins VP, Reifenberger G, Lichter P: Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 94:14719-14724, 1997.
47. Yamashita J, Handa H, Iwaki K, Abe M: Recurrence of intracranial meningiomas, with special reference to radiotherapy. Surg Neurol 14:33-44, 1980.
48. Zang KD: Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 6:249-274, 1982.
49. Zang KD, Singer H: Chromosomal constitution of meningiomas. Nature 216:84-85, 1967.
50. Zankl H, Zang KD: Correlation between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet 1:351-356, 1980.